Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease

The biomarkers of Parkinson’s disease (PD) remain to be investigated. This work aimed to identify blood biomarkers for PD using targeted metabolomics analysis. We quantified the plasma levels of 255 metabolites in 92 PD patients and 60 healthy controls (HC). PD patients were sub-grouped into early (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Kuo-Hsuan, Cheng, Mei-Ling, Tang, Hsiang-Yu, Huang, Cheng-Yu, Wu, Hsiu-Chuan, Chen, Chiung-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834036/
https://www.ncbi.nlm.nih.gov/pubmed/35159203
http://dx.doi.org/10.3390/cells11030395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834036/
https://www.ncbi.nlm.nih.gov/pubmed/35159203
http://dx.doi.org/10.3390/cells11030395

Ejemplares similares